CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk-Reference-Cited by-同舟云学术

CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk

Published:2022-05 Issue:5 Volume:54 Page:637-648
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Baer Constance,Kimura Shunsuke^ORCID,Rana Mitra S.^ORCID,Kleist Andrew B.,Flerlage Tim,Feith David J.^ORCID,Chockley Peter^ORCID,Walter Wencke^ORCID,Meggendorfer Manja,Olson Thomas L.,Cheon HeeJin,Olson Kristine C.,Ratan Aakrosh^ORCID,Mueller Martha-Lena,Foran James M.,Janke Laura J.,Qu Chunxu,Porter Shaina N.,Pruett-Miller Shondra M.^ORCID,Kalathur Ravi C.^ORCID,Haferlach Claudia,Kern Wolfgang,Paietta Elisabeth,Thomas Paul G.^ORCID,Babu M. Madan^ORCID,Loughran Thomas P.,Iacobucci Ilaria^ORCID,Haferlach Torsten^ORCID,Mullighan Charles G.^ORCID

Funder

Center for Strategic Scientific Initiatives, National Cancer Institute

Henry Schueler 41 & 9 Foundation St. Baldrick’s Foundation Robert J. Arceci Innovation Award

Garwood Postdoctoral Fellowship of the Hematological Malignancies Program of the St Jude Children’s Research Hospital Comprehensive Cancer Center

U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences

U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine

the Bess Family Charitable Fund, the LGL Leukemia Foundation and a generous anonymous donor

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

https://www.nature.com/articles/s41588-022-01059-2.pdf

Reference89 articles.

1. Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375–2390 (2016).

2. Barila, G. et al. T cell large granular lymphocyte leukemia and chronic NK lymphocytosis. Best. Pract. Res. Clin. Haematol. 32, 207–216 (2019).

3. Lamy, T., Moignet, A. & Loughran, T. P. Jr LGL leukemia: from pathogenesis to treatment. Blood 129, 1082–1094 (2017).

4. Giussani, E. et al. Lack of viral load within chronic lymphoproliferative disorder of natural killer cells: what is outside the leukemic clone? Front Oncol. 10, 613570 (2020).

5. Lamy, T. & Loughran, T. P. Jr How I treat LGL leukemia. Blood 117, 2764–2774 (2011).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancers;Expert Opinion on Therapeutic Targets;2024-09-05

2. New insights on Epstein-Barr virus-induced lymphomagenesis;Science Bulletin;2024-08

3. Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype;Expert Review of Clinical Immunology;2024-07-24

4. Unlocking a genetic model of NK-cell transformation;Blood;2024-06-13

5. A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia;Blood;2024-06-13